BHMT and digestive system neoplasm: In addition to hyperhomocysteinemia, Bhmt−/− mice show 48% lower liver SAM content, 21-fold-higher liver betaine, and histological evidence of liver steatosis compared to the Bhmt+/+ mice [4].